XML 87 R74.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Guarantor Financial Information - Consolidating Statement of Comprehensive Income (Details) - USD ($) $ in Millions | 3 Months Ended
--- | ---
Jul. 28, 2017 | Jul. 29, 2016
Condensed Statement of Income Captions [Line Items] |  |
Net sales | $ 7,390 | $ 7,166
Costs and expenses: |  |
Cost of products sold | 2,349 | 2,261
Research and development expense | 548 | 556
Selling, general, and administrative expense | 2,485 | 2,428
Restructuring charges, net | 8 | 94
Certain litigation charges | 0 | 82
Acquisition-related items | 44 | 52
Divestiture-related items | 47 | 0
Amortization of intangible assets | 454 | 487
Other expense, net | 66 | 39
Operating profit | 1,389 | 1,167
Interest income | (92) | (93)
Interest expense | 286 | 272
Interest expense, net | 194 | 179
Equity in net (income) loss of subsidiaries | 0 | 0
Income before provision for income taxes | 1,195 | 988
Provision for income taxes | 186 | 59
Net income | 1,009 | 929
Net loss attributable to noncontrolling interests | 7 | 0
Net income attributable to Medtronic | 1,016 | 929
Other comprehensive income (loss), net of tax | 689 | (156)
Comprehensive loss attributable to noncontrolling interests | 7 | 0
Comprehensive income attributable to Medtronic | 1,705 | 773
Consolidating Adjustments | Medtronic Senior Notes |  |
Condensed Statement of Income Captions [Line Items] |  |
Net sales | (303) | (348)
Costs and expenses: |  |
Cost of products sold | (306) | (354)
Research and development expense | 0 | 0
Selling, general, and administrative expense | 0 | 0
Restructuring charges, net | 0 | 0
Certain litigation charges |  | 0
Acquisition-related items | 0 | 0
Divestiture-related items | 0 |
Amortization of intangible assets | 0 | 0
Other expense, net | 0 | 0
Operating profit | 3 | 6
Interest income | 423 | 405
Interest expense | (423) | (405)
Interest expense, net | 0 | 0
Equity in net (income) loss of subsidiaries | 2,898 | 2,933
Income before provision for income taxes | (2,895) | (2,927)
Provision for income taxes | 0 | 0
Net income | (2,895) |
Net loss attributable to noncontrolling interests | 0 |
Net income attributable to Medtronic | (2,895) | (2,927)
Other comprehensive income (loss), net of tax | (1,362) | 233
Comprehensive loss attributable to noncontrolling interests | 0 |
Comprehensive income attributable to Medtronic | (4,257) | (2,694)
Consolidating Adjustments | CIFSA Senior Notes |  |
Condensed Statement of Income Captions [Line Items] |  |
Net sales | 0 | 0
Costs and expenses: |  |
Cost of products sold | 0 | 0
Research and development expense | 0 | 0
Selling, general, and administrative expense | 0 | 0
Restructuring charges, net | 0 | 0
Certain litigation charges |  | 0
Acquisition-related items | 0 | 0
Divestiture-related items | 0 |
Amortization of intangible assets | 0 | 0
Other expense, net | 0 | 0
Operating profit | 0 | 0
Interest income | 148 | 199
Interest expense | (148) | (199)
Interest expense, net | 0 | 0
Equity in net (income) loss of subsidiaries | 2,471 | 2,635
Income before provision for income taxes | (2,471) | (2,635)
Provision for income taxes | 0 | 0
Net income | (2,471) |
Net loss attributable to noncontrolling interests | 0 |
Net income attributable to Medtronic | (2,471) | (2,635)
Other comprehensive income (loss), net of tax | (1,472) | 270
Comprehensive loss attributable to noncontrolling interests | 0 |
Comprehensive income attributable to Medtronic | (3,943) | (2,365)
Medtronic plc | Reportable Legal Entities | Medtronic Senior Notes |  |
Condensed Statement of Income Captions [Line Items] |  |
Net sales | 0 | 0
Costs and expenses: |  |
Cost of products sold | 0 | 0
Research and development expense | 0 | 0
Selling, general, and administrative expense | 3 | 3
Restructuring charges, net | 0 | 0
Certain litigation charges |  | 0
Acquisition-related items | 0 | 0
Divestiture-related items | 0 |
Amortization of intangible assets | 0 | 0
Other expense, net | 13 | 11
Operating profit | (16) | (14)
Interest income | 0 | 0
Interest expense | 49 | 16
Interest expense, net | 49 | 16
Equity in net (income) loss of subsidiaries | (1,079) | (957)
Income before provision for income taxes | 1,014 | 927
Provision for income taxes | (2) | (2)
Net income | 1,016 |
Net loss attributable to noncontrolling interests | 0 |
Net income attributable to Medtronic | 1,016 | 929
Other comprehensive income (loss), net of tax | 689 | (156)
Comprehensive loss attributable to noncontrolling interests | 0 |
Comprehensive income attributable to Medtronic | 1,705 | 773
Medtronic plc | Reportable Legal Entities | CIFSA Senior Notes |  |
Condensed Statement of Income Captions [Line Items] |  |
Net sales | 0 | 0
Costs and expenses: |  |
Cost of products sold | 0 | 0
Research and development expense | 0 | 0
Selling, general, and administrative expense | 3 | 3
Restructuring charges, net | 0 | 0
Certain litigation charges |  | 0
Acquisition-related items | 0 | 0
Divestiture-related items | 0 |
Amortization of intangible assets | 0 | 0
Other expense, net | 13 | 11
Operating profit | (16) | (14)
Interest income | 0 | 0
Interest expense | 49 | 16
Interest expense, net | 49 | 16
Equity in net (income) loss of subsidiaries | (1,079) | (957)
Income before provision for income taxes | 1,014 | 927
Provision for income taxes | (2) | (2)
Net income | 1,016 |
Net loss attributable to noncontrolling interests | 0 |
Net income attributable to Medtronic | 1,016 | 929
Other comprehensive income (loss), net of tax | 689 | (156)
Comprehensive loss attributable to noncontrolling interests | 0 |
Comprehensive income attributable to Medtronic | 1,705 | 773
Subsidiary Issuer | Reportable Legal Entities | Medtronic Senior Notes |  |
Condensed Statement of Income Captions [Line Items] |  |
Net sales | 303 | 348
Costs and expenses: |  |
Cost of products sold | 222 | 250
Research and development expense | 158 | 163
Selling, general, and administrative expense | 301 | 280
Restructuring charges, net | 1 | 16
Certain litigation charges |  | 0
Acquisition-related items | 29 | 23
Divestiture-related items | 9 |
Amortization of intangible assets | 2 | 3
Other expense, net | (477) | (640)
Operating profit | 58 | 253
Interest income | (71) | (60)
Interest expense | 441 | 408
Interest expense, net | 370 | 348
Equity in net (income) loss of subsidiaries | (815) | (1,174)
Income before provision for income taxes | 503 | 1,079
Provision for income taxes | (77) | 22
Net income | 580 |
Net loss attributable to noncontrolling interests | 0 |
Net income attributable to Medtronic | 580 | 1,057
Other comprehensive income (loss), net of tax | (7) | 95
Comprehensive loss attributable to noncontrolling interests | 0 |
Comprehensive income attributable to Medtronic | 573 | 1,152
Subsidiary Issuer | Reportable Legal Entities | CIFSA Senior Notes |  |
Condensed Statement of Income Captions [Line Items] |  |
Net sales | 0 | 0
Costs and expenses: |  |
Cost of products sold | 0 | 0
Research and development expense | 0 | 0
Selling, general, and administrative expense | 0 | 0
Restructuring charges, net | 0 | 0
Certain litigation charges |  | 0
Acquisition-related items | 0 | 0
Divestiture-related items | 0 |
Amortization of intangible assets | 0 | 0
Other expense, net | 1 | 1
Operating profit | (1) | (1)
Interest income | (16) | (29)
Interest expense | 23 | 32
Interest expense, net | 7 | 3
Equity in net (income) loss of subsidiaries | (390) | (877)
Income before provision for income taxes | 382 | 873
Provision for income taxes | 0 | 0
Net income | 382 |
Net loss attributable to noncontrolling interests | 0 |
Net income attributable to Medtronic | 382 | 873
Other comprehensive income (loss), net of tax | 94 | 42
Comprehensive loss attributable to noncontrolling interests | 0 |
Comprehensive income attributable to Medtronic | 476 | 915
Subsidiary Guarantors | Reportable Legal Entities | Medtronic Senior Notes |  |
Condensed Statement of Income Captions [Line Items] |  |
Net sales | 0 | 0
Costs and expenses: |  |
Cost of products sold | 0 | 0
Research and development expense | 0 | 0
Selling, general, and administrative expense | 0 | 0
Restructuring charges, net | 0 | 0
Certain litigation charges |  | 0
Acquisition-related items | 0 | 0
Divestiture-related items | 0 |
Amortization of intangible assets | 0 | 0
Other expense, net | 0 | 0
Operating profit | 0 | 0
Interest income | (110) | (156)
Interest expense | 35 | 1
Interest expense, net | (75) | (155)
Equity in net (income) loss of subsidiaries | (1,004) | (802)
Income before provision for income taxes | 1,079 | 957
Provision for income taxes | 0 | 0
Net income | 1,079 |
Net loss attributable to noncontrolling interests | 0 |
Net income attributable to Medtronic | 1,079 | 957
Other comprehensive income (loss), net of tax | 689 | (156)
Comprehensive loss attributable to noncontrolling interests | 0 |
Comprehensive income attributable to Medtronic | 1,768 | 801
Subsidiary Guarantors | Reportable Legal Entities | CIFSA Senior Notes |  |
Condensed Statement of Income Captions [Line Items] |  |
Net sales | 0 | 0
Costs and expenses: |  |
Cost of products sold | 0 | 0
Research and development expense | 0 | 0
Selling, general, and administrative expense | 0 | 0
Restructuring charges, net | 0 | 0
Certain litigation charges |  | 0
Acquisition-related items | 0 | 0
Divestiture-related items | 0 |
Amortization of intangible assets | 0 | 0
Other expense, net | 0 | 0
Operating profit | 0 | 0
Interest income | (112) | (157)
Interest expense | 35 | 1
Interest expense, net | (77) | (156)
Equity in net (income) loss of subsidiaries | (1,002) | (801)
Income before provision for income taxes | 1,079 | 957
Provision for income taxes | 0 | 0
Net income | 1,079 |
Net loss attributable to noncontrolling interests | 0 |
Net income attributable to Medtronic | 1,079 | 957
Other comprehensive income (loss), net of tax | 689 | (156)
Comprehensive loss attributable to noncontrolling interests | 0 |
Comprehensive income attributable to Medtronic | 1,768 | 801
Subsidiary Non-guarantors | Reportable Legal Entities | Medtronic Senior Notes |  |
Condensed Statement of Income Captions [Line Items] |  |
Net sales | 7,390 | 7,166
Costs and expenses: |  |
Cost of products sold | 2,433 | 2,365
Research and development expense | 390 | 393
Selling, general, and administrative expense | 2,181 | 2,145
Restructuring charges, net | 7 | 78
Certain litigation charges |  | 82
Acquisition-related items | 15 | 29
Divestiture-related items | 38 |
Amortization of intangible assets | 452 | 484
Other expense, net | 530 | 668
Operating profit | 1,344 | 922
Interest income | (334) | (282)
Interest expense | 184 | 252
Interest expense, net | (150) | (30)
Equity in net (income) loss of subsidiaries | 0 | 0
Income before provision for income taxes | 1,494 | 952
Provision for income taxes | 265 | 39
Net income | 1,229 |
Net loss attributable to noncontrolling interests | 7 |
Net income attributable to Medtronic | 1,236 | 913
Other comprehensive income (loss), net of tax | 680 | (172)
Comprehensive loss attributable to noncontrolling interests | 7 |
Comprehensive income attributable to Medtronic | 1,916 | 741
Subsidiary Non-guarantors | Reportable Legal Entities | CIFSA Senior Notes |  |
Condensed Statement of Income Captions [Line Items] |  |
Net sales | 7,390 | 7,166
Costs and expenses: |  |
Cost of products sold | 2,349 | 2,261
Research and development expense | 548 | 556
Selling, general, and administrative expense | 2,482 | 2,425
Restructuring charges, net | 8 | 94
Certain litigation charges |  | 82
Acquisition-related items | 44 | 52
Divestiture-related items | 47 |
Amortization of intangible assets | 454 | 487
Other expense, net | 52 | 27
Operating profit | 1,406 | 1,182
Interest income | (112) | (106)
Interest expense | 327 | 422
Interest expense, net | 215 | 316
Equity in net (income) loss of subsidiaries | 0 | 0
Income before provision for income taxes | 1,191 | 866
Provision for income taxes | 188 | 61
Net income | 1,003 |
Net loss attributable to noncontrolling interests | 7 |
Net income attributable to Medtronic | 1,010 | 805
Other comprehensive income (loss), net of tax | 689 | (156)
Comprehensive loss attributable to noncontrolling interests | 7 |
Comprehensive income attributable to Medtronic | $ 1,699 | $ 649

X
- Definition Disposition of Business, Related Expenses + References No definition available. + Details
Name: | mdt_DispositionofBusinessRelatedExpenses
Namespace Prefix: | mdt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of expenses, net of reversals, associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to discontinued operation or an asset retirement obligation. + References No definition available. + Details
Name: | mdt_RestructuringChargesNetofRestructuringReversals
Namespace Prefix: | mdt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -URI http://asc.fasb.org/extlink&oid=84229725&loc=d3e1043-128460 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=84228862&loc=d3e557-108580 + Details
Name: | us-gaap_ComprehensiveIncomeNetOfTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4613674-111683 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4569643-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686 + Details
Name: | us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CondensedStatementOfIncomeCaptionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a),(d)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CostsAndExpensesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after tax of income (loss) of subsidiary attributable to the parent entity. + References No definition available. + Details
Name: | us-gaap_IncomeLossFromSubsidiariesNetOfTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeTaxExpenseBenefit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of the cost of borrowed funds accounted for as interest expense. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28555-108399 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 + Details
Name: | us-gaap_InterestExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net amount of nonoperating interest income (expense). + References No definition available. + Details
Name: | us-gaap_InterestIncomeExpenseNonoperatingNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of interest income earned from interest bearing assets classified as other. + References No definition available. + Details
Name: | us-gaap_InterestIncomeOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349 + Details
Name: | us-gaap_LossContingencyAccrualProvision
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=84161450&loc=SL4573702-111684 + Details
Name: | us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_NonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after tax and reclassification adjustments of other comprehensive income (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=84228862&loc=SL7669619-108580 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -URI http://asc.fasb.org/extlink&oid=84228862&loc=SL7669625-108580 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 55 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=84158357&loc=d3e1436-108581 + Details
Name: | us-gaap_OtherComprehensiveIncomeLossNetOfTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4569616-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=84161450&loc=SL4573702-111684 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=84161450&loc=SL4573702-111684 + Details
Name: | us-gaap_ProfitLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 + Details
Name: | us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311 + Details
Name: | us-gaap_SellingGeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_ConsolidationEliminationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=mdt_GuarantorsMedtronicNotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=mdt_CIFSANotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidatedEntitiesAxis=us-gaap_ParentCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_ReportableLegalEntitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidatedEntitiesAxis=us-gaap_SubsidiaryIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidatedEntitiesAxis=us-gaap_GuarantorSubsidiariesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidatedEntitiesAxis=us-gaap_NonGuarantorSubsidiariesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |